Phibro Animal Health (PAHC) Enterprise Value (2013 - 2026)

Phibro Animal Health's Enterprise Value history runs 14 years deep, the most recent figure standing at -$77.5 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 10.09% year-over-year to -$77.5 million in Q1 2026; TTM through Mar 2026 was -$77.5 million, a 10.09% decrease from a year earlier, with the FY2025 full-year figure at -$77.0 million, up 32.78% from the prior year.
• Enterprise Value declined to -$77.5 million in Q1 2026 per PAHC's latest filing, from -$74.5 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$67.1 million in Q4 2024 and bottomed at -$114.6 million in Q2 2024.
• The 5-year median for Enterprise Value is -$85.3 million (2025), against an average of -$85.1 million.
• Across the five-year window, Enterprise Value tumbled 41.01% in 2024 and jumped 32.78% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$78.4 million in 2022, then declined by 17.94% to -$92.5 million in 2023, then gained by 27.48% to -$67.1 million in 2024, then decreased by 11.08% to -$74.5 million in 2025, then fell by 3.95% to -$77.5 million in 2026.
• Per Business Quant, the three latest PAHC Enterprise Value figures stand at -$77.5 million (Q1 2026), -$74.5 million (Q4 2025), and -$85.3 million (Q3 2025).